• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hepatocellular carcinoma in the absence of liver cirrhosis in a treated hepatitis C virus patient.

作者信息

Al Nozha Omar M, Al Ashgar Hamad, Khan Mohammed, Al Mana Hadeel

出版信息

Ann Saudi Med. 2009 May-Jun;29(3):235-6. doi: 10.4103/0256-4947.51789.

DOI:10.4103/0256-4947.51789
PMID:19448362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2813657/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d50/2813657/67f292f036a9/ASM-29-235-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d50/2813657/486357bfa122/ASM-29-235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d50/2813657/35732a3d6266/ASM-29-235-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d50/2813657/67f292f036a9/ASM-29-235-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d50/2813657/486357bfa122/ASM-29-235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d50/2813657/35732a3d6266/ASM-29-235-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d50/2813657/67f292f036a9/ASM-29-235-g003.jpg

相似文献

1
Hepatocellular carcinoma in the absence of liver cirrhosis in a treated hepatitis C virus patient.一名接受治疗的丙型肝炎病毒患者在无肝硬化情况下发生肝细胞癌。
Ann Saudi Med. 2009 May-Jun;29(3):235-6. doi: 10.4103/0256-4947.51789.
2
Occurrence of hepatocellular carcinoma upon advanced liver fibrosis thirteen years after achieving sustained virological response to hepatitis C: how long surveillance should be maintained?丙型肝炎实现持续病毒学应答十三年后，晚期肝纤维化患者发生肝细胞癌：应维持多长时间的监测？
Dig Dis Sci. 2015 Feb;60(2):582-5. doi: 10.1007/s10620-014-3378-x. Epub 2014 Oct 15.
3
Emerging therapies of hepatitis B and C.乙型和丙型肝炎的新兴疗法。
J Gastroenterol Hepatol. 2002 Dec;17 Suppl:S471-81. doi: 10.1046/j.1440-1746.17.s4.13.x.
4
[Hepatitis C and liver transplantation].[丙型肝炎与肝移植]
Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B82-90.
5
Hepatocellular Carcinoma Risk Declines but Remains High Enough for Screening in the First 7 Years After Hepatitis C Virus Cure With Direct-Acting Antivirals in Patients With Cirrhosis or High Fibrosis-4 Score.在肝硬化或纤维化-4评分高的患者中，使用直接抗病毒药物治愈丙型肝炎病毒后的前7年，肝细胞癌风险下降，但仍高到足以进行筛查。
Gastroenterology. 2022 Oct;163(4):1104-1106.e3. doi: 10.1053/j.gastro.2022.06.057. Epub 2022 Jun 28.
6
[Chronic hepatitis C: from discovery to cure].[慢性丙型肝炎：从发现到治愈]
Zhonghua Gan Zang Bing Za Zhi. 2016 Sep 20;24(9):708-712. doi: 10.3760/cma.j.issn.1007-3418.2016.09.016.
7
Hepatocellular carcinoma developed in a patient with chronic hepatitis C after the disappearance of hepatitis C virus due to interferon therapy.一名慢性丙型肝炎患者在接受干扰素治疗后丙型肝炎病毒消失，随后发生了肝细胞癌。
Hepatogastroenterology. 1999 Jul-Aug;46(28):2554-60.
8
Hepatitis C Genotype 3 Infection: Pathogenesis and Treatment Horizons.丙型肝炎基因型 3 感染：发病机制和治疗前景。
Clin Liver Dis. 2017 Nov;21(4):645-657. doi: 10.1016/j.cld.2017.06.009. Epub 2017 Aug 5.
9
Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.在澳大利亚新南威尔士州直接作用抗病毒治疗时代，丙型肝炎病毒相关肝病负担下降。
J Hepatol. 2019 Aug;71(2):281-288. doi: 10.1016/j.jhep.2019.04.014. Epub 2019 May 10.
10
Summaries for patients. Long-term effects of antiviral treatment for hepatitis C.患者摘要。丙型肝炎抗病毒治疗的长期效果。
Ann Intern Med. 2005 Jan 18;142(2):I51. doi: 10.7326/0003-4819-142-2-200501180-00004.

引用本文的文献

1
HEPATOCELLULAR CARCINOMA IN A NON-CIRRHOTIC PATIENT WITH SUSTAINED VIROLOGICAL RESPONSE AFTER HEPATITIS C TREATMENT.丙型肝炎治疗后获得持续病毒学应答的非肝硬化患者中的肝细胞癌
Rev Inst Med Trop Sao Paulo. 2015 Dec;57(6):519-22. doi: 10.1590/S0036-46652015000600011.

本文引用的文献

1
Natural course of asymptomatic hepatitis C virus-infected patients and hepatocellular carcinoma after interferon therapy.无症状丙型肝炎病毒感染患者的自然病程及干扰素治疗后的肝细胞癌
Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S89-91. doi: 10.1016/s1542-3565(05)00701-9.
2
Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy.
Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S141-3. doi: 10.1016/s1542-3565(05)00713-5.
3
Screening for hepatocellular carcinoma.肝细胞癌筛查
Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):101-18. doi: 10.1016/j.bpg.2004.11.006.
4
Viral hepatitis C.丙型病毒性肝炎
Lancet. 2003 Dec 20;362(9401):2095-100. doi: 10.1016/s0140-6736(03)15109-4.
5
Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.意大利有肝硬化和无肝硬化的肝细胞癌患者的病因
Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):213-6.
6
[Hepatocellular carcinoma associated to porphyria cutanea tarda and hepatitis C virus infection without cirrhosis].迟发性皮肤卟啉症及丙型肝炎病毒感染相关的肝细胞癌（无肝硬化）
Rev Esp Enferm Dig. 1998 Jan;90(1):48-50.
7
Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study.实时超声检查对肝细胞癌的早期检测。一项前瞻性研究。
Cancer. 1985 Aug 1;56(3):660-6. doi: 10.1002/1097-0142(19850801)56:3<660::aid-cncr2820560338>3.0.co;2-f.